- Home
- » Tags
- » Benznidazole
Top View
- Nifurtimox Versus Benznidazole Or Placebo for Asymptomatic Trypanosoma Cruzi Infection
- Final1-Aritmo-Final-Report-V2-0Final.Pdf
- Doxycycline and Benznidazole Reduce the Profile of Th1, Th2, and Th17 Chemokines and Chemokine Receptors in Cardiac Tissue from Chronic Trypanosoma Cruzi-Infected Dogs
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- 209570Orig1s000
- The Selection and Use of Essential Medicines
- Drugs for Parasitic Infections (2013 Edition)
- Identification of Trypanosoma Cruzi Growth Inhibitors with Activity In
- Drug Transporter and Oxidative Stress Gene Expression in Human Macrophages Infected with Benznidazole-Sensitive and Naturally Be
- In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma Cruzi Strains Belonging to Discrete Typing Units
- Anti-Trypanosoma Cruzi Activity of Nicotinamide
- Antibody Drop in Newborns Congenitally Infected by Trypanosoma Cruzi Treated with Benznidazole
- Doxycycline Hyclate a Schistosomicidal Agent in Vitro with Immunomodulatory Potential on Granulomatous Inflammation in Vivo
- Benznidazole Reference Number: CP.PMN.90 Effective Date: 03.01.18 Last Review Date: 02.21 Line of Business: Commercial, HIM, Medicaid Revision Log
- Amebic Meningoencephalitis.Qxd
- Biopharmaceutical Optimization in Neglected Diseases for Paediatric Patients by Applying the Provisional Paediatric Biopharmaceutical Classification System
- Australian Statistics on Medicines 2009
- Identification of Inhibitors to Trypanosoma Cruzi Sirtuins Based on Compounds Developed to Human Enzymes
- Vitro Drug Susceptibility of Two Strains of the Wildlife Trypanosome, Trypanosoma Copemani: a Comparison with Trypanosoma Cruzi
- The Medical Letter
- Medications for Parasitic Infections Duration Limit for 30-Day Period
- Antiparasitic Therapy
- In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma Cruzi Strains Belonging to Discrete Typing Units Tci
- Nifurtimox, Benznidazole, and Metronidazole
- Download (Accessed on 20 July 2019)
- New Child-Adapted Chagas Disease Treatment Approved for Registration
- The Medical Letter
- POM Analyses of Antitrypanosomal Activity of 2-Iminobenzimidazoles: Favorable and Unfavorable Parameters for Drugs Optimization
- Guidelines for ATC Classification and DDD Assignment 2021
- BENZNIDAZOLE TABLETS Safely and Effectively
- The Role of Benznidazole with Cyanocobalamin and Ascorbic Acid in Treating the Chronic Phase of Chagas Disease Letter
- Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma Cruzi Strain in Mice
- 50 Years After Nifurtimox: Current and Future Chemotherapy for Chagas Disease
- 18Th Expert Committee on the Selection and Use of Essential Medicines Reviewer No
- Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma Cruzi Strain
- Tolerance of Benznidazole in a United States Chagas Disease Clinic
- Cautious Optimism?
- Ch-1 a Comparison of the in Vivoand in Vitroactivity of Pentostam of Chinese Origin and Glucantime Against Leishmania Brasiliens
- Guidelines for ATC Classification and DDD Assignment 2013
- The Selection and Use of Essential Medicines
- ROS and Trypanosoma Cruzi: Fuel to Infection, Poison to the Heart
- The Medical Letter
- Benznidazole Reference Number: ERX.SPA.227 Effective Date: 10.17.17 Last Review Date: 02.18 Revision Log
- Doxycycline and Benznidazole Reduce the Profile of Th1, Th2, and Th17 Chemokines and Chemokine Receptors in Cardiac Tissue from Chronic Trypanosoma Cruzi-Infected Dogs
- Phenothiazinium Dyes Are Active Against Trypanosoma Cruzi in Vitro
- In Vitro Susceptibility of Trypanosoma Cruzi Strains from Santander, Colombia, to Hexadecylphosphocholine
- The Selection and Use of Essential Medicines
- Purification of the Antichagasic Benznidazole from the Commercial Preparation Rocheganr